Analysts Set Pediatrix Medical Group, Inc. (NYSE:MD) PT at $10.30

Pediatrix Medical Group, Inc. (NYSE:MD) has earned an average recommendation of “Hold” from the four brokerages that are presently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $10.30.

A number of brokerages have weighed in on MD. Jefferies Financial Group dropped their price target on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, March 6th. Truist Financial reduced their price target on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating on the stock in a research report on Wednesday, February 21st. TheStreet cut shares of Pediatrix Medical Group from a “c” rating to a “d” rating in a report on Friday, February 23rd. Finally, Mizuho reduced their price objective on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st.

Pediatrix Medical Group Trading Up 1.6 %

Shares of MD stock opened at $9.04 on Thursday. Pediatrix Medical Group has a 1-year low of $7.70 and a 1-year high of $15.06. The company has a market cap of $759.63 million, a price-to-earnings ratio of -12.38, a PEG ratio of 2.40 and a beta of 1.58. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24. The stock has a 50 day simple moving average of $9.20 and a 200-day simple moving average of $9.61.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.30 by $0.02. The company had revenue of $496.44 million during the quarter, compared to analyst estimates of $524.30 million. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. Pediatrix Medical Group’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.46 EPS. On average, equities research analysts expect that Pediatrix Medical Group will post 1.12 EPS for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Institutional investors have recently made changes to their positions in the stock. SummerHaven Investment Management LLC boosted its position in Pediatrix Medical Group by 2.3% during the fourth quarter. SummerHaven Investment Management LLC now owns 52,900 shares of the company’s stock worth $492,000 after purchasing an additional 1,208 shares in the last quarter. Nordea Investment Management AB boosted its position in shares of Pediatrix Medical Group by 0.6% in the 3rd quarter. Nordea Investment Management AB now owns 219,561 shares of the company’s stock worth $2,810,000 after buying an additional 1,221 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Pediatrix Medical Group by 9.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,340 shares of the company’s stock valued at $208,000 after acquiring an additional 1,443 shares during the last quarter. Performa Ltd US LLC increased its holdings in Pediatrix Medical Group by 130.8% during the 4th quarter. Performa Ltd US LLC now owns 3,000 shares of the company’s stock valued at $28,000 after acquiring an additional 1,700 shares in the last quarter. Finally, Swiss National Bank raised its position in Pediatrix Medical Group by 1.1% during the third quarter. Swiss National Bank now owns 174,900 shares of the company’s stock worth $2,223,000 after acquiring an additional 1,900 shares during the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.